CLOSE X
Company Profile
more from company profile
HomeMarkets Company Profile Board Meeting

Board Meeting

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE847.0033.45 (+4.11 %)
PREV CLOSE ( ) 813.55
OPEN PRICE ( ) 841.05
BID PRICE (QTY) 846.55 (37)
OFFER PRICE (QTY) 847.00 (45)
VOLUME 189432
TODAY'S LOW / HIGH ( )838.10 862.65
52 WK LOW / HIGH ( )660.05 1504
NSE843.0029.45 (+3.62 %)
PREV CLOSE( ) 813.55
OPEN PRICE ( ) 845.00
BID PRICE (QTY) 843.10 (1)
OFFER PRICE (QTY) 843.40 (94)
VOLUME 2290964
TODAY'S LOW / HIGH( ) 839.10 864.80
52 WK LOW / HIGH ( )726.8 1505
Source Date Board Meeting Date Details
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.